Virt-Nate Tablets, Number of units per package: 100 Tablets Package Type: 100 Tablets/Bottle
Recalling firm: VIRTUS PHARMACEUTICALS LLC.
Virtus Pharmaceuticals, LLC has decided to initiate a recall of the following products : Virt-Nate Tablets and Virt Gard Tablets because product labels do not reflect the correct amount of Dietary Folate Equivalents (DFEs) calculated based on the product formulation.
Check your package
Compare the exact product and package details with the label you have.
FDA code information
Lot# M185860 Expiration Date: 12/2018 Lot# M1903000 Expiration Date: 4/2019
Match the product, package size, and code together. A missing match does not guarantee safety.
Full FDA record and distribution details
Original product description
Virt-Nate Tablets, Number of units per package: 100 Tablets Package Type: 100 Tablets/Bottle
Extracted codes and context
| Type | Code / value | Context |
|---|---|---|
| lot | M185860 | Lot# M185860 Expiration Date: 12/2018 Lot# M1903000 Expiration Date: 4/2019 |
| lot | M1903000 | Lot# M185860 Expiration Date: 12/2018 Lot# M1903000 Expiration Date: 4/2019 |
Recall details
- Recall number
- F-1932-2018
- Event ID
- 80772
- FDA status
- Terminated
- Initiated
- Aug 3, 2018
- Reported
- Sep 12, 2018
- Classified
- Sep 4, 2018
- Terminated
- Apr 6, 2019
- Quantity
- 2209 Bottles
- Location
- Newtown, PA, United States
- Initiation type
- Voluntary: Firm initiated
- Notification
- Letter
Where it was distributed
Virt Nate: Arizona, Colorado, Illinois, Indiana, Michigan, Minnesota, Missouri, Mississippi, New Jersey, New York, Ohio, Oklahoma, Pennsylvania, Texas, Virginia, Vermont and Wisconsin. Virt Gard: Arizona, California, Colorado, Florida, Georgia, Iowa, Illinois, Kentucky, Massachusetts, Michigan, Missouri, Mississippi, North Carolina, New Jersey, New York, Ohio, Pennsylvania, South Carolina, Texas, Virginia and West Virginia.
Data updated September 16, 2026. View official FDA data ↗
Follow official FDA and manufacturer guidance.